Perbak Capital Partners LLP Acquires New Holdings in Waters Co. (NYSE:WAT)

Perbak Capital Partners LLP bought a new stake in Waters Co. (NYSE:WAT) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 3,654 shares of the medical instruments supplier’s stock, valued at approximately $1,356,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Aster Capital Management DIFC Ltd acquired a new position in shares of Waters in the 4th quarter valued at $28,000. Bank of Jackson Hole Trust acquired a new stake in shares of Waters during the 4th quarter worth approximately $34,000. Fortitude Family Office LLC grew its holdings in Waters by 235.7% during the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock valued at $35,000 after purchasing an additional 66 shares during the period. Steward Partners Investment Advisory LLC grew its holdings in Waters by 129.3% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier’s stock valued at $35,000 after purchasing an additional 53 shares during the period. Finally, Murphy & Mullick Capital Management Corp acquired a new position in shares of Waters in the fourth quarter valued at approximately $42,000. Institutional investors and hedge funds own 94.01% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Wells Fargo & Company increased their price objective on shares of Waters from $415.00 to $420.00 and gave the stock an “overweight” rating in a research note on Thursday, February 13th. UBS Group raised their target price on shares of Waters from $405.00 to $410.00 and gave the stock a “neutral” rating in a report on Thursday, February 13th. Barclays decreased their price objective on shares of Waters from $400.00 to $350.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 10th. Baird R W raised shares of Waters from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, March 26th. Finally, JPMorgan Chase & Co. increased their price target on Waters from $380.00 to $390.00 and gave the company a “neutral” rating in a research note on Thursday, March 6th. Ten analysts have rated the stock with a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $392.13.

Waters Trading Up 0.7 %

Shares of NYSE WAT opened at $340.10 on Tuesday. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14. The business has a fifty day simple moving average of $355.22 and a two-hundred day simple moving average of $370.45. The firm has a market cap of $20.23 billion, a PE ratio of 31.76, a price-to-earnings-growth ratio of 3.79 and a beta of 1.04. Waters Co. has a twelve month low of $279.24 and a twelve month high of $423.56.

Waters (NYSE:WAT) last released its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. Analysts expect that Waters Co. will post 12.86 earnings per share for the current fiscal year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.